
    
      The AOTI two2 therapy trial is a randomized, double-blinded, parallel group,
      placebo-controlled, multi-center study intended to evaluate the efficacy of Topical Wound
      Oxygen (two2) therapy in relation to placebo when added to standard of care in the treatment
      of diabetic lower extremity ulcers.
    
  